IgG(1) pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality

OBJECTIVES: We aimed to define the clinical and serological characteristics of pan-neurofascin antibody-positive patients. METHODS: We tested serum from patients with suspected immune-mediated neuropathies for antibodies directed against nodal/paranodal protein antigens using a live cell-based assay...

Descripción completa

Detalles Bibliográficos
Autores principales: Fehmi, Janev, Davies, Alexander J, Walters, Jon, Lavin, Timothy, Keh, Ryan, Rossor, Alexander M, Munteanu, Tudor, Delanty, Norman, Roberts, Rhys, Bäumer, Dirk, Lennox, Graham, Rinaldi, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Neuromuscular
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458075/
https://www.ncbi.nlm.nih.gov/pubmed/34400540
http://dx.doi.org/10.1136/jnnp-2021-326343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458075/
https://www.ncbi.nlm.nih.gov/pubmed/34400540
http://dx.doi.org/10.1136/jnnp-2021-326343

Ejemplares similares